Treating Patients with Heart Failure Using a Respiratory Resistance Therapeutic Device

Overview

About this study

The purpose of this study is to investigate the potential benefits to pulmonary function using a unique respiratory “training mask” during exercise on patients with heart failure.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion criteria:

  • 18 to 85 years of age;
  • NYHA class I-III HF with stable pharmacological therapy;
  • Enrolled in the cardiac rehabilitation program at Mayo Clinic;
  • Able to perform exercise without orthopedic limitations;
  • Able to consent for themselves.

Exclusion criteria:

  • Severe COPD;
  • HF with LVAD;
  • Using supplemental oxygen during daily activities or exercise.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Bruce Johnson, Ph.D.

Open for enrollment

Contact information:

Jordan Parks B.S.

(480) 301-6616

Parks.Jordan@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20502524

Mayo Clinic Footer